drug disposition & excretion
TRANSCRIPT
![Page 1: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/1.jpg)
DRUG DISPOSITIONAND EXCRETION
PRESENTED by k.b.GAUThAmI
m-PhARmACy 1ST yEAR II SEm
(PhARmACEUTICS)
ROll NO: 256213886009.
![Page 2: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/2.jpg)
![Page 3: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/3.jpg)
bIOTRANSFORmATION
• Chemical alteration of a substance within the body, as by the action of enzymes
• Vital to survival
• Key in defense mechanism….
![Page 4: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/4.jpg)
METABOLISM OR BIOTRANSFORMATION The conversion from one chemical form of a substance to another.
The term metabolism is commonly used probably because products of drug transformation are called metabolites.
Metabolism is an essential pharmacokinetic process, which renders lipid soluble and non-polar compounds to water soluble and polar compounds so that they are excreted by various processes.
This is because only water-soluble substances undergo excretion, whereas lipid soluble substances are passively reabsorbed from renal or extra renal excretory sites into the blood by virtue of their lipophilicity.
Metabolism is a necessary biological process that limits the life of a substance in the body.
Biotransformation: It is a specific term used for chemical transformation of xenobiotics in the body/living organism.
• A series of enzyme-catalyzed processes—that alters the physiochemical properties of foreign chemicals (drug/xenobiotics) from those that favor absorption across biological membranes (lipophilicity) to those favoring elimination in urine or bile (hydrophilicity )
![Page 5: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/5.jpg)
Metabolism : It is a general term used for chemical transformation of xenobiotics and endogenous nutrients (e.g., proteins, carbohydrates and fats) within or outside the body.
Xenobiotics : These are all chemical substances that are not nutrient for body (foreign to body) and which enter the body through ingestion, inhalation or dermal exposure.
They include : drugs, industrial chemicals, pesticides, pollutants,
plant and animal toxins, etc.
![Page 6: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/6.jpg)
Site/Organs of drug metabolism
The major site of drug metabolism is the liver (microsomal enzyme systems of hepatocytes)
Secondary organs of biotransformation • kidney (proximal tubule) • lungs (type II cells) • testes (Sertoli cells)• skin (epithelial cells); plasma. nervous tissue
(brain); intestines
![Page 7: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/7.jpg)
Hepatic microsomal enzymes (oxidation, conjugation)
Extrahepatic microsomal enzymes (oxidation, conjugation)
Hepatic non-microsomal enzymes (acetylation, sulfation,GSH, alcohol/aldehyde dehydrogenase,hydrolysis, ox/red)
Drug Metabolism
![Page 8: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/8.jpg)
![Page 9: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/9.jpg)
![Page 10: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/10.jpg)
UPTAKE
ORGAN
EXCRETION
ORGAN
UPTAKE
EXCRETION
Primarily biotransformation makeslipophilic compounds more hydrophilic
UPTAKE
EXCRETION
BIOTRANS-FORMATION
Uptake and excretion of hydrophilic and lipophilic compounds
![Page 11: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/11.jpg)
REACTIONS
• PHASE I : modification
• PHASE II : conjugation
![Page 12: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/12.jpg)
TYPES OF BIOTRANSFORMATION
Phase 1 reaction. (Non synthetic phase)
A change in drug molecule. generally results in the introduction of a
functional group into molecules or the exposure of new functional groups of
molecules : Phase I (non-synthetic or non-
conjugative phase) includes reactions which catalyse oxidation, reduction and hydrolysis of drugs.
In phase I reactions, small polar functional groups like-OH, -NH2. -SH, -COOH, etc. are either added or unmasked (if already present) on the lipid soluble drugs so that the resulting products may undergo phase II reactions.
• result in activation, change or inactivation of drug.
Phase II reaction. (Synthetic phase)• Last step in detoxification reactions
and almost always results in loss of biological activity of a compound.
• May be preceded by one or more of phase one reaction
• Involves conjugation of functional groups of molecules with hydrophilic endogenous substrates- formation of conjugates - is formed with (an endogenous substance such as carbohydrates and amino acids. )with drug or its metabolites formed in phase 1 reaction.
Involve attachment of small polar endogenous molecules like glucuronic acid, sulphate, methyl, amino acids, etc., to either unchanged drugs or phase I products.
Products called as 'conjugates' are water-soluble metabolites, which are readily excreted from the body.
![Page 13: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/13.jpg)
• Phase I metabolism is sometimes called a “functionalization reaction,”
• Results in the introduction of new hydrophilic functional groups to compounds.
• Function: introduction (or unveiling) of functional group(s) such as –OH, –NH2, –SH, –COOH into the compounds.
• Reaction types: oxidation, reduction, and hydrolysis
• Enzymes:• Oxygenases and oxidases: Cytochrome P450 (P450
or CYP), flavincontaining• monooxygenase (FMO), peroxidase, monoamine
oxidase(MAO), alcohol dehydrogenase, aldehyde dehydrogenase, and xanthine 0xidase. Reductase: Aldo-keto reductase and quinone reductase.
• Hydrolytic enzymes: esterase, amidase, aldehyde oxidase, and alkylhydrazine
• oxidase.• Enzymes that scavenge reduced oxygen:
Superoxide dismutases, catalase,• glutathione peroxidase, epoxide hydrolase, y-
glutamyl transferase,• dipeptidase, and cysteine conjugate β-lyase
• Phase II metabolism includes what are known as conjugation reactions.
• Generally, the conjugation reaction with endogenous substrates occurs on the metabolite( s) of the parent compound after phase I metabolism; however, in some cases, the parent compound itself can be subject to phase II metabolism.
• Function: conjugation (or derivatization) of functional groups of a compound or its metabolite(s) with endogenous substrates.
• Reaction types: glucuronidation, sulfation, glutathione-conjugation, Nacetylation, methylation and conjugation with amino acids (e.g., glycine, taurine, glutamic acid).
• Enzymes: Uridine diphosphate-Glucuronosyltransferase (UDPGT): sulfotransferase (ST), N-acetyltransferase, glutathione S-transferase (GST),methyl transferase, and amino acid conjugating enzymes.
• Glucuronidation by uridine diphosphate-glucuronosyltransferase; Sulfation by sulfotransferase
• 3. Acetylation by N-acetyltransferase; Glutathione conjugation by glutathione S-transferase;. Methylation by methyl transferase; Amino acid conjugation
![Page 14: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/14.jpg)
![Page 15: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/15.jpg)
A small polar group is either exposed on the toxicant or added to the toxicant…
Oxidation
Reduction
Hydrolysis
Acetylation
![Page 16: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/16.jpg)
PHASE I REACTION
OXIDATION substrate loses electrons
addition of oxygen, dehydrogenation, or
simply transfer of electrons…
![Page 17: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/17.jpg)
alcohol dehydrogenation aldehyde dehydrogenation alkyl/acyclic hydroxylation aromatic hydroxylation deamination desulfuration N-dealkylation N-hydroxylation N-oxidation O-dealkylation sulphoxidation
![Page 18: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/18.jpg)
Aliphatic hydroxylation
Aromatic hydroxylation
R R OH
R - CH CH - R’ R - CH - CH - R’
Epoxidation
O
N-, O-, or S-dealkylation
R - (N, O, S) - CH3
H
N - hydroxylation
Deamination
R - C - H + NH3
O
OO
R - NH - C – CH3 R - NOH - C – CH3
R - C - H R - C - OH R - C - H + HX
OX X
H H
R - S - R’ R - S - R’
Sulphur oxidation
S
R1R2P - X R1R2P - X + S
O
De-sulphurnation
Oxidative dehalogenation
R - CH2 – CH2 – CH3 R – CH2 – CHOH – CH3
R – (NH2, OH, SH) + CH2O
R – CH2 – NH2
![Page 19: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/19.jpg)
PHASE I REACTION
REDUCTION Substrate gains electrons Occurs when oxygen content is low Common reaction
azo reduction dehalogenation disulfide reduction nitro reduction N-oxide reduction sulfoxide reduction
![Page 20: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/20.jpg)
![Page 21: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/21.jpg)
PHASE I REACTION
HYDROLYSIS Addition of water splits the molecule into
two fragments or smaller molecules
-OH gp to one fragment and –H to other
Eg : Larger chemicals such as esters, amines, hydrazines, and carbamates
![Page 22: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/22.jpg)
![Page 23: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/23.jpg)
Conjugation
Endogenous substance is added to the reactive site of the Phase I metabolite
more water-soluble
![Page 24: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/24.jpg)
![Page 25: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/25.jpg)
TYPE I
• Methylation
• Glucuronidation
• Sulfation
• Acetylation
TYPE II
• Peptide conjugation
• Glutathione conjugation
• Glycosylation
![Page 26: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/26.jpg)
glucuronide conjugation
sulfate conjugation
acetylation
amino acid conjugation
glutathione conjugation
methylation
![Page 27: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/27.jpg)
COFACTORSCOFACTORSTYPE 1- REacTIvE/ acTIvaTEd
cofacToR a)UDP- Glucuronic acid
b)PAPS
c)Acetyl CoA
d)SAM
![Page 28: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/28.jpg)
TYPE 2- REacTIvE XEnobIoTIc
a)Glutathione
b)Aminoacids(glycine,glutamine,
taurine)
![Page 29: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/29.jpg)
Glucuronosyltransferase
Sulfotransferase
Glutathione-S-transferase
Acetyltransferase
![Page 30: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/30.jpg)
GLUCURONIDE CONJUGATION glucuronic acid from glucose Sites involve substrates having O2, N2 or S
bonds Includes xenobiotics as well as endogenous
substances Reduces toxicity..(sometimes produce
carcinogenic substances) Excreted: kidney or bile depending on
conjugate size
![Page 31: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/31.jpg)
![Page 32: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/32.jpg)
GLUcURonIdE conJUGaTIon
R – OH + UDPO
HO
O
OH
OH
COOH
Glucuronyltransferase O
HO
O
OH
OH
COOH
R + UDP
![Page 33: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/33.jpg)
SULPHATE CONJUGATION Decreases toxicity readily excreted by urine Sulphotransferase PAPS limits the pathway
![Page 34: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/34.jpg)
SULFATE CONJUGATION
![Page 35: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/35.jpg)
glucuronidation or sulfation can conjugate the same xenobiotics
Primary, secondary, phenols, catechols, N-oxides, amines undergo this…
![Page 36: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/36.jpg)
GLUTATHIONE CONJUGATION Conjugate loses glutamic acid and glycine
Cysteine is N-acetylated to give stable mercapturic acid derivatives
![Page 37: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/37.jpg)
N
O
H
O
H
N
S
H
O
N
O
O
H H
OH
H
H+
+
N
OO
O
H H
O
H
H
N
O
S
H H
O
H
N
O
HH
O
H
Glutamicacid
Cysteine
GlycineGlutathione
![Page 38: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/38.jpg)
![Page 39: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/39.jpg)
![Page 40: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/40.jpg)
ACETYLATION the water solubility of parent molecule
and their excretion Masks the functional group of parent
from participating in conjugations Acetyl transferases Aromatic amines or hydrazine group to
amides or hydrazides
![Page 41: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/41.jpg)
Methylation Makes slightly less soluble Masks available functional groups Types
O- methylation
N- methylation
S- methylation
![Page 42: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/42.jpg)
![Page 43: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/43.jpg)
PHASE II REACTIONS
• Aminoacid conjugation
![Page 44: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/44.jpg)
GENETICSNfr2- nuclear factor erythroid derived
Inactive oxidative stress active
CP nucleus
![Page 45: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/45.jpg)
ENZYMES
ENZYMESmicrosomal…. Phase I and glucuronidation enzymesCytosolic enzymes….phase II and oxidation and
reductionMitochondrial, nuclei and lysosomes contain a little
transforming activity….
![Page 46: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/46.jpg)
MICROSOMALPhase I reactions
– Most oxidation and reduction
– Some hydrolysis
Phase II reactions– ONLY Glucuronide
conjugation• Inducible
– Drugs, diet, etc.
• SER
NONMICROSOMALPhase I reactions
– Most hydrolysis– Some oxidation and
reductionPhase II reactions
ALL except Glucuronide conjugation
• Not inducible• CP, MT etc
![Page 47: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/47.jpg)
ENZYMES
• High molecular weight proteins..
![Page 48: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/48.jpg)
MONOOXYGENASESCYTOCHROME P450 ENZYME SYSTEM
• Mixed function oxidase
• Commonly in microsomes
• Important in plant terpenoid biosynthesis
• In phase I reactions
• Contains 2 enz NADPH CYP reductase and cyp 450
![Page 49: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/49.jpg)
CYTOCHROME P450 ENZYME SYSTEMCYTOCHROME P450 ENZYME SYSTEM
superfamily of heme-dependent proteinsexpressed in mammals mainly in the liver,
with lower levels of expression in the small intestine, lungs, kidneys, brain and placenta
In man, to date 57 different P450 isoforms have been identified, which were assigned to 18 families and 43 subfamilies based on their protein sequences
![Page 50: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/50.jpg)
REDUCTASE
P-450P-450
![Page 51: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/51.jpg)
TYPES
• Microsomal P450 systems: electrons are transferred from NADPH via cytochrome P450 reductase.
• Mitochondrial P450 systems: employ adrenodoxin reductase and adrenodoxin to transfer electrons from NADPH to P450.
![Page 52: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/52.jpg)
CYTOCHROME P 450 ENZYME ACTION
![Page 53: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/53.jpg)
HC(inducer)
Ah receptor-hsp90
HC
P450 mRNAP450 protein
• Bioactivation• Detoxification
Toxicity
Elimination
Cell
HC-AhR
hsp90
HC-AhR
XRE
P450 gen
Nucleus
HC: Hydrocarbon (inducer)XRC: Regulator gene (stimulates transcription of P-450 gene)
![Page 54: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/54.jpg)
P450 family Function
CYP1, CYP2, CYP3 Metabolism of drugs and xenobiotics
CYP4, CYP5, CYP8
Fatty acids hydroxylation, biosynthesis of prostaglandins, prostacyclins and thromboxanes
CYP7, CYP11, CYP17, CYP19 (=steroid aromatase), CYP21, CYP24, CYP27, CYP39, CYP46, CYP51 Biosynthesis and metabolism of cholesterol, steroid
hormones and bile acids
CYP26 Retinoic acid hydroxylation
CYP20 Unknown
![Page 55: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/55.jpg)
FLAVIN MONO OXYGENASE
• Microsomal enzyme
• mixed function amine oxidase
• Cofactors: NADPH, molecular O₂
• Do not contain heme
• Broad specificity
• Nicotine detoxification
![Page 56: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/56.jpg)
OTHER ENZYMES
• Monoamine oxidases- breakdown of neurotransmitters and antidepressant drugs
• Alcohol and aldehyde dehydrogenases
![Page 57: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/57.jpg)
TYPES OF FACTORS
• Chemical
• Biological
• Altered Physiological
• Temporal
• Route of Drug Administration
• Enviornmental
![Page 58: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/58.jpg)
Chemical Factors
1. Enzyme Induction
2. Enzyme Inhibition
![Page 59: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/59.jpg)
Enzyme Induction
It is a process in which a drug induces or enhances the expression of an enzyme.
Rifampicin If taken by female patients taking contraceptives, causes decreased therapeutic effect, leading to pregnancy.
Phenobarbitone If administered to patients taking warfarin, may cause therapeutic failure, leading to increased bleeding tendency.
Auto induction: The phenomenon in which a
drug induces metabolism of other drugs as well
as its own E.g. carbamazepine-antiepileptic.
![Page 60: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/60.jpg)
Enzyme Inhibition
Decrease in the drug metabolizing ability of
enzymes. Competition for the active sites
takes place between the inhibitor and the
drugs. When enzyme inhibitor attaches,
less metabolism occurs. E.g. Sulfonamides decrease the metabolism of phenytoin so
that its blood levels become toxic. Cimetidine decreases the metabolism of propanolol
leading to enhanced bradycardia. Oral contraceptives inhibit metabolism of antipyrine.
![Page 61: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/61.jpg)
Biological FactorsAGE
In infants microsomal enzyme system is not fully developed. The rate of metabolism is very low. Care should be taken in administering drugs in younger patients.
Chloramphenicol does not have great efficacy in infants. Toxic effects in the form of grey baby syndrome might occur. The baby may be cyanosed, hypothermic, flaccid and grey in color. Shock and even death might occur if toxic levels get accumulated.
Diazepam may result in floppy baby syndrome in which flaccidity of the baby is seen.
![Page 62: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/62.jpg)
AGE
In elderly, most processes slow down which leads to decreased metabolism. Shrinkage of organs occurs as well along with decreased liver functions and decreased blood flow through the liver. All these factors decrease the metabolism.
The drug doses should be decreased in the elderly
![Page 63: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/63.jpg)
GENDER
Gender related differences in the rate of metabolism are attributed to sex hormones and are generally observed following puberty.
Male have a higher BMR as compared to the females, thus can metabolize drugs more efficiently, e.g. salicylates and others might include ethanol, propanolol, benzodiazepines.
Women on oral contraceptives metabolize drugs at a slower rate
![Page 64: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/64.jpg)
GENETICS
Drugs behave differently in different individuals due to genetic variations
Succinyl choline, which is a skeletal muscle relaxant, is metabolized by pseudocholine esterase. Some people lack this enzyme, due to which lack of metabolism of succinyl choline might occur. When administered in those individuals, prolonged Apnea might result.
Different groups of populations might be classified as fast metabolizers and poor metabolizers of drugs.For drugs, like Isoniazid, fast acetylators as well as slow acetylators are present. Fast acetylators cause rapid acetylation, while poor metabolizers metabolize less. Hepatic acetyl transferrase catalyzes acetylation. Slow acetylation might occur due to genetic malformation leading to decreased production.
![Page 65: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/65.jpg)
RACE/SPECIES
Asians, Orientals, Blacks and Whites might have different drug metabolizing capacity. Examples include difference in drug metabolizing capacity of certain anti malarial.
Eskimos metabolize drugs faster than Asians.
Laboratory animals can metabolize drugs faster than man e.g. barbiturates.
![Page 66: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/66.jpg)
DIET
The enzyme content and activity is altered by a number of dietary components.
Low protein diet decreases and high protein content in diet increases the drug metabolizing ability.
Dietary deficiency of vitamins and minerals retard the metabolic activity of enzymes.
![Page 67: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/67.jpg)
ALTERED PHYSIOLOGICAL FACTORSPREGNANCYDuring pregnancy, metabolism of some
drugs is increased while that of others is decreased due to the presence of steroid hormones e.g.
Phenytoin Phenobarbitone Pethidine
![Page 68: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/68.jpg)
HORMONAL IMBALANCE
Higher levels of one hormone may inhibit the activity of few enzymes while inducing that of others. E.g.
Hypothyroidism increases drug metabolizing capacity (increased half life of antipyrine, digoxin, methimazole, practolol) while hyperthyroidism decreases it.
![Page 69: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/69.jpg)
DISEASE STATES
Liver disease such as hepatic carcinoma, cirrhosis, hepatitis, obstructive jaundice etc reduce the hepatic drug metabolizing ability and thus increase the half lives of almost all drugs.
In renal diseases conjugation of salycylates, oxidation of vitamin D and hydrolysis of Procaine are impaired.
Cardiovascular diseases, although have no direct effect, decrease the blood flow, which may slow down biotransformation of drugs like isoniazid, morphine and propanolol.
Pulmonary conditions may decrease biotransformation. Procaine and procainamide hydrolysis is impaired.
![Page 70: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/70.jpg)
TEMPORAL FACTOR
Diurnal variations and variations in enzyme activity with light cycle is circadian rhythm.
Enzyme action is maximum during early morning and minimum in late afternoon which is probably due to high levels of coticosterone.
![Page 71: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/71.jpg)
ROUTE OF ADMINISTRATION
Oral route can result in extensive hepatic metabolism of some drugs (first pass effect).
Lignocaine is almost completely metabolized if taken by oral route therefore the preferable route is Topical.
![Page 72: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/72.jpg)
ENVIRONMENTAL FACTORS
Aromatic hydrocarbon contained in Cigarette smokers act as enzyme inducers.
Chronic alcoholism might lead to enzyme induction as well.
Pesticides or Organophosphate insecticides may act as enzyme inducers.
In hot and humid climate biotransformation is decreased and vice versa.
At high altitude decreased biotransformation occurs due to decreased oxygen leading to decreased oxidation of drugs.
![Page 73: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/73.jpg)
REFERENCE
• http://www.eoearth.org/article/Biotransformation?topic=58074• profiles.nlm.nih.gov/ps/access/CCAAOR.pdf• www.slideshare.net/shishirkawde/biotransformation-10417087• www.eolss.net/sample-chapters/c17/e6-58-04-06.pdf• www.ncbi.nlm.nih.gov/pubmed/3116933• ingentaconnect.com RK Venisetty, V Ciddi - Current pharmaceutical
biotechnology, 2003 • web.squ.edu.om/med-Lib/MED_CD/E_CDs/.../020160r00.HTM• www.eoearth.org/article/Biotransformation
![Page 74: Drug disposition & excretion](https://reader030.vdocuments.mx/reader030/viewer/2022013118/55a73e161a28abe6258b48c4/html5/thumbnails/74.jpg)